Physician profile
David E Hald
NPI 1588621056
$1,259.01
in general payments reported to CMS, 2019-2025
13 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $87.53 · 2021: $166 · 2022: $109 · 2023: $194 · 2024: $528 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $896.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $728.90 | 2021-2025 | General - Erectile Dysfunction, Ams 800 Artificial Urinary Sphincter |
| Janssen Biotech, INC. | $148.89 | 2024 | Erleada |
| Urogen Pharma, INC. | $92.57 | 2021 | |
| Elekta, INC. | $69.21 | 2020 | |
| Abbvie INC. | $37.99 | 2021-2024 | |
| Blue Earth Diagnostics | $32.24 | 2024 | |
| Allergan, INC. | $29.62 | 2022 | |
| 180 Medical, INC. | $23.39 | 2022 | |
| Accord Healthcare, INC. | $22.55 | 2024 | |
| Progenics Pharmaceuticals, INC. | $20.17 | 2023 | Pylarify |
| Angiodynamics, INC. | $19.10 | 2023 | Nanoknife |
| Endo Pharmaceuticals INC. | $18.32 | 2020 | |
| Medtronic, INC. | $16.06 | 2024 | Interstim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.